| Group 2B-1 (n = 8) | Group 2B-2 (n = 11) | P-value4 |
---|---|---|---|
Gender (Male/Female) | 4/4 | 9/2 | 0.32 |
Patient Age (years) | 62.8 ± 9.9 | 59.1 ± 9.9 | 0.44 |
(Range, Median) | (46–74, 63) | (40–76, 59) | |
Tumor Size (mm) | 9.4 ± 1.9 | 15.3 ± 6.1 | 0.01 |
(Range, Median) | (6–12, 10) | (8–28, 15) | |
Location (C-A/T) 1 | 3/5 | 10/1 | 0.041 |
Crypt Branching 2 (+/total) | 0/8 | 8/11 | 0.003 |
Hypermucinous 3 (+/total) | 8/8 | 11/11 | 1.00 |
Carcinoma in adenoma (+/total) | 0/8 | 1/11 | 1.00 |